Table 1.
LACRC Recruitment Methods and Characteristics of Study Samples (N=1,170)
| Study | Participation Rates | Sources | Recruitment Methods | Consent Type | Country of Origin | Gender | Education (≤High School) | Age, y | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Posters | Flyers | Radio | Referral2 | Incentive | ||||||||
| Cancer prevention priorities (N=88) | 93% | Clinic, community sites | – | X | – | X | $50 Cash | Written | United States 8% Mexico 10% Central America 60% South America 16% Other 7% | Male 56% | 51% | 13–60 |
| RCT feasibility (N=79) | 96% | Clinic | – | X | – | – | – | Verbal | N/D | Female 100% | N/D | 36–91 |
| Breast cancer prevention* (N=450) | 95% | Clinic | X | X | – | X | $15 Gift card | Written | Central America 51.42% South America 27.36% Other 21.22% | Female 100% | 70% | 33–81 |
| Latina trust (N=178) | 95% | Clinic, community sites | X | X | X | – | $10 Gift card | Verbal | Central America 31% South America 57% North America 8% Other 4% | Female 100% | 55% | 21–90 |
| Tobacco use (N=305) | 97% | Clinic and ancillary services, health fair, community sites | X | X | X | X | $10 Gift card | Written | United States 2.3% Mexico 9.2% Central America Caribbean 51.5% South America 30.9% Other 5.25% | Male 65% | 66% | 18–76 |
| Colorectal screening (N=70) | 98% | Clinic, food program, community sites, female focus groups. | X | X | X | X | $50 Cash | Written | Mexico 2% Central America 39% South America 55% Other 2% | Male 28% | 43% | 50–80 |
*
Combined two studies of breast cancer risk and STAR enrollment intervention from family members, or social network.
LACRC, Latin American Cancer Research Coalition; N/D, not determined; RCT, randomized clinical trial; STAR, Study of Tamoxifen and Raloxifene.